In that study, levels of sPD-1 and sPD-L1 were closely correlated and elevated in association with an elevated c-reactive protein, suggestive of systemic inflammation, and tumor infiltration with T cells, which was consistent with an active anti-tumor immune response that was being blunted. The gene discussed is HOXD13; the disease is neoplasm.